Clinical Trials on Nonconvulsive Seizures

Total 895 results

Supernus Pharmaceuticals, Inc.

Recruiting

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Epilepsy | Seizures, Epileptic

Australia
University of Colorado, Denver
University of Colorado, Boulder

Recruiting

A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures

Epilepsy

United States
Beijing Children's Hospital

Active, not recruiting

A China RWS to Evaluate the Effectiveness and Safety of Perampanel as an add-on Treatment for Epileptic Seizure

Epilepsy

China
Centre Hospitalier Saint Joseph Saint Luc de Lyon
RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la...

Unknown

Epidemiology of Suspected Epileptic Seizures (EPI-lepsie)

Epilepsy

France
University of Aarhus
Aarhus University Hospital

Completed

Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask (EpiCapno)

Epilepsy

Denmark
Eisai Inc.

Completed

E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Epilepsy

United States
Biolert

Completed

Study of Algorithm for Epilepsy Alert Device

Motor Seizures
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM (LVT2)

Epilepsy | Seizure | Cerebral Malaria

Malawi
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

Epilepsy | Partial Seizures With or Without Secondary Generalization

China, Japan, Malaysia, Philippines, Singapore, Taiwan, Thailand
UCB Biopharma S.P.R.L.

Completed

A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Epilepsy | Partial Seizures With or Without Secondary Generalization

Japan
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (LVT1)

Epilepsy | Seizure | Cerebral Malaria

Malawi
Cambridge University Hospitals NHS Foundation Trust
Norfolk and Norwich University Hospitals NHS Foundation Trust; Luton and Dunstable... and other collaborators

Recruiting

EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy (EAGLET)

Neonatal Seizures

United Kingdom
Beijing Children's Hospital

Active, not recruiting

A Multi-center RWS of Perampanel as an add-on Treatment for Epileptic Seizures in Chinese Children

Epilepsy

China
Whanin Pharmaceutical Company

Completed

Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult

Partial-onset Seizures With or Without Secondary Generalisation

Korea, Republic of
UCB Pharma SA

Completed

Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

Epilepsy | Partial Seizures

China
Cairo University

Unknown

Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG

Neonatal Seizures

Egypt
Eisai Inc.

Completed

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Epilepsy

Greece, Italy, Spain, Sweden, Korea, Republic of, Germany, Australia, France, Switzerland, Slovakia, Poland, Taiwan, Hungary, Serbia, India, United Kingdom, Denmark, Russian Federation, South Africa, Montenegro
Jazz Pharmaceuticals

Completed

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Epilepsy

United States, Finland
University of Glasgow
William Quarriers Scottish Epilepsy Centre

Recruiting

Assessing the Impact of Brief CBTi on Dissociative Seizures: SCED (CBTi 4 DS:SCED)

Sleep Disorder | Insomnia | Dissociative Seizures | Dissociation | Psychogenic Nonepileptic Seizures | Functional Seizures

United Kingdom
UCB Biopharma SRL

Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures (LENS)

Epilepsy | Electroencephalographic Neonatal Seizures

United States, Australia, Canada
UCB BIOSCIENCES, Inc.

Completed

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures (VALUE)

Epilepsy

United States, Australia, Brazil, Bulgaria, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Epilepsy | Partial Onset Seizures

Japan
UCB Japan Co. Ltd.

Completed

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Epilepsy | Partial Onset Seizures

Japan
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

Seizures, Epileptic
University Hospital, Lille

Unknown

Development of an Epileptic Seizure Detection Algorithm by Continuous Analysis of the Electrocardiogram (EPICARD)

Epilepsy | Seizures | Electrocardiography

France
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

Epilepsy | Partial Seizures
UCB Pharma

Completed

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Epilepsy
University Hospital, Basel, Switzerland
University Children's Hospital Basel

Completed

Copeptin in Childhood Epilepsy (EpiCop)

Epilepsy | Children | Febrile Seizures

Switzerland
UCB Pharma SA
UCB Japan Co. Ltd.

Completed

Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

China, Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Epilepsies, Partial

United States, Korea, Republic of, Hungary, India, Czechia, Bulgaria, Mexico, Poland, Thailand
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Epilepsies, Partial

Japan
UCB Japan Co. Ltd.

Completed

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

Japan
UCB Japan Co. Ltd.

Completed

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Epilepsy | Generalized Tonic-Clonic Seizures

China, Japan
Brain Sentinel

Completed

Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

Epilepsy | Generalized Tonic-Clonic Seizures

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Epilepsy

United States, Ukraine, Hong Kong, Czechia
Markus Schuelke, M.D.
University of Kiel; Ludwig-Maximilians - University of Munich; University of Ulm and other collaborators

Completed

Clinical-genetic Investigations in Children With Early Infantile Epilepsies

Epilepsy | Seizures, Infantile

Germany
Valexfarm

Completed

Remegal Different Doses in Patients With Refractory Partial Seizures

Self Efficacy | Drug Safety | Normal Drug Tolerance

Russian Federation
University of Edinburgh
NHS Lothian

Completed

Preliminary Testing of a Novel Device to Detect Epileptic Seizures (PTEpD)

Epilepsy

United Kingdom
UCB Japan Co. Ltd.

Completed

An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures

Epilepsy | Partial Seizures

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Once-A-Day Pregabalin For Partial Seizures

Epilepsies, Partial | Partial Seizures

United States, Singapore, Malaysia, Hungary, Czechia, India, Hong Kong, Mexico, Thailand, Argentina, Bosnia and Herzegovina, Bulgaria, Germany, Poland, Puerto Rico, Romania, Russian Federation, Serbia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures

Epilepsies, Partial

United States, Ukraine, Hong Kong, Czechia
UCB BIOSCIENCES, Inc.
Pharmaceutical Research Associates

Completed

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications (VALOR)

Epilepsy

United States, Australia, Belgium, Brazil, Bulgaria, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan
UCB Pharma SA
UCB Japan Co. Ltd.

Completed

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

Epilepsy | Partial Onset Seizures

China, Japan
UCB Japan Co. Ltd.
Parexel

Completed

Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures

Epilepsy | Partial-onset Seizures

Japan
UCB BIOSCIENCES, Inc.

Completed

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures

Epilepsy With Partial-onset Seizures

United States, Argentina, Brazil, Bulgaria, China, Croatia, Czechia, France, Georgia, Greece, Hungary, Israel, Italy, Korea, Republic of, Mexico, Moldova, Republic of, Philippines, Poland, Portugal, Romania, Russian Federation, Se... and more
Eisai Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy

Epilepsy | Partial-onset Seizures
Eisai GmbH

Terminated

Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization

Epilepsy

Germany
Neurelis, Inc.

Completed

Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects

Acute Repetitive Seizures

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years (PERIWINKLE)

Epilepsy, Partial Seizures

Korea, Republic of, United States, Singapore, Malaysia, Czechia, France, Greece, Hungary, Israel, Italy, Philippines, Poland, Romania, Serbia, Turkey, Ukraine, Belgium, Bulgaria
Eisai Inc.

Completed

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Epilepsy; Paediatric Partial Onset Seizures

Belgium, France, Italy, Spain, Estonia, Hungary, Poland, Ukraine, Latvia

Clinical Trials on Nonconvulsive Seizures

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations